Acadia Healthcare (ACHC) to Release Quarterly Earnings on Wednesday

Acadia Healthcare (NASDAQ:ACHC) will post its quarterly earnings results after the market closes on Wednesday, May 1st. Analysts expect Acadia Healthcare to post earnings of $0.80 per share for the quarter. Individual interested in listening to the company’s earnings conference call can do so using this link.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Wednesday, February 28th. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.80 by $0.05. The firm had revenue of $742.80 million during the quarter, compared to analysts’ expectations of $727.60 million. Acadia Healthcare had a negative net margin of 0.74% and a positive return on equity of 11.21%. The firm’s revenue for the quarter was up 10.0% compared to the same quarter last year. During the same period last year, the firm posted $0.70 earnings per share. On average, analysts expect Acadia Healthcare to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Acadia Healthcare Stock Up 0.7 %

Shares of NASDAQ:ACHC opened at $70.74 on Wednesday. Acadia Healthcare has a 52 week low of $66.49 and a 52 week high of $87.77. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.67 and a current ratio of 0.67. The company has a market cap of $6.54 billion, a PE ratio of -282.95, a price-to-earnings-growth ratio of 2.07 and a beta of 1.31. The firm has a 50 day simple moving average of $78.68 and a 200 day simple moving average of $77.72.

Wall Street Analyst Weigh In

ACHC has been the subject of several analyst reports. Barclays began coverage on shares of Acadia Healthcare in a research note on Wednesday, March 6th. They issued an “overweight” rating and a $100.00 price objective for the company. Mizuho upped their target price on shares of Acadia Healthcare from $77.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, March 6th. UBS Group boosted their price target on shares of Acadia Healthcare from $88.00 to $102.00 and gave the stock a “buy” rating in a research note on Wednesday, February 28th. TheStreet raised shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Finally, Cantor Fitzgerald restated a “neutral” rating and set a $90.00 target price on shares of Acadia Healthcare in a report on Tuesday, March 5th. Three equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $94.75.

Insider Activity

In other news, Director Wade D. Miquelon sold 2,203 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $85.39, for a total value of $188,114.17. Following the transaction, the director now owns 46,074 shares in the company, valued at approximately $3,934,258.86. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.80% of the stock is currently owned by corporate insiders.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.